Panoptes Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $8.36M

Panoptes Pharma General Information

Description

Provider of molecule-based therapies intended to help in the treatment of severe eye diseases. The company's molecule-based therapies focus on a new treatment for autoimmune uveitis and adenoviral conjunctivitis and have therapeutic potential for additional inflammatory and viral indications, enabling patients with unmet medical needs to have access to novel eye treatment.

Contact Information

Website
www.panoptes-pharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Reisnerstraße 34/1
  • Vienna, 1030
  • Austria
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Kiora Pharmaceuticals
Corporate Office
  • Reisnerstraße 34/1
  • Vienna, 1030
  • Austria

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Panoptes Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 18-Dec-2020 $8.36M Completed Clinical Trials - General
4. Seed Round 02-Nov-2015 Completed Clinical Trials - General
3. Grant Completed Clinical Trials - General
2. Seed Round 26-Sep-2013 $1.6M $1.63M Completed Clinical Trials - General
1. Accelerator/Incubator $35.3K $35.3K Completed Clinical Trials - General
To view Panoptes Pharma’s complete valuation and funding history, request access »

Panoptes Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of molecule-based therapies intended to help in the treatment of severe eye diseases. The company's molecule-ba
Drug Discovery
Vienna, Austria
5 As of 2020

San Diego, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Panoptes Pharma Competitors (39)

One of Panoptes Pharma’s 39 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Genentech Formerly VC-backed South San Francisco, CA
Foventa Therapeutics Venture Capital-Backed Cambridge, United Kingdom
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 39 competitors. Get the full list »

Panoptes Pharma Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Panoptes Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3859631-A1 Telescopic mast with rfid antennas for warehouse inventories Active 31-Jan-2020
EP-3859631-B1 Telescopic mast with rfid antennas for warehouse inventories Active 31-Jan-2020

Panoptes Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Panoptes Pharma Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
4SC Corporation Minority
ARAX Capital Partners Venture Capital Minority
Austria Wirtschaftsservice Venture Capital Minority
INiTS Universitäres Gründerservice Accelerator/Incubator
Life Science Austria Government Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Panoptes Pharma FAQs

  • When was Panoptes Pharma founded?

    Panoptes Pharma was founded in 2013.

  • Where is Panoptes Pharma headquartered?

    Panoptes Pharma is headquartered in Vienna, Austria.

  • What is the size of Panoptes Pharma?

    Panoptes Pharma has 5 total employees.

  • What industry is Panoptes Pharma in?

    Panoptes Pharma’s primary industry is Drug Discovery.

  • Is Panoptes Pharma a private or public company?

    Panoptes Pharma is a Private company.

  • What is the current valuation of Panoptes Pharma?

    The current valuation of Panoptes Pharma is .

  • What is Panoptes Pharma’s current revenue?

    The current revenue for Panoptes Pharma is .

  • How much funding has Panoptes Pharma raised over time?

    Panoptes Pharma has raised $2.75M.

  • Who are Panoptes Pharma’s investors?

    4SC, ARAX Capital Partners, Austria Wirtschaftsservice, INiTS Universitäres Gründerservice, and Life Science Austria are 5 of 7 investors who have invested in Panoptes Pharma.

  • Who are Panoptes Pharma’s competitors?

    ACADIA Pharmaceuticals, Genentech, Foventa Therapeutics, ONL Therapeutics, and Neurona Therapeutics are some of the 39 competitors of Panoptes Pharma.

  • When was Panoptes Pharma acquired?

    Panoptes Pharma was acquired on 18-Dec-2020.

  • Who acquired Panoptes Pharma?

    Panoptes Pharma was acquired by Kiora Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process